Kaken Pharmaceutical Revenue

Kaken Pharmaceutical had revenue of 24.62B JPY in the quarter ending December 31, 2024, with 32.97% growth. This brings the company's revenue in the last twelve months to 93.35B, up 29.48% year-over-year. In the fiscal year ending March 31, 2024, Kaken Pharmaceutical had annual revenue of 72.04B, down -1.29%.

Revenue (ttm)

93.35B

Revenue Growth

+29.48%

P/S Ratio

1.94

Revenue / Employee

82.25M

Employees

1,135

Market Cap

180.89B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	72.04B	-940.00M	-1.29%
Mar 31, 2023	72.98B	-3.05B	-4.01%
Mar 31, 2022	76.03B	1.06B	1.41%
Mar 31, 2021	74.98B	-14.25B	-15.97%
Mar 31, 2020	89.23B	-4.93B	-5.24%
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro
Mar 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,170.61B
Takeda Pharmaceutical Company	4,579.02B
Daiichi Sankyo Company	1,795.99B
HOYA Corporation	837.44B
Otsuka Holdings	2,329.86B
Terumo	1,011.15B
Astellas Pharma	1,867.63B
Olympus	993.33B

Revenue Rankings

Kaken Pharmaceutical News

4 months ago - Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - Benzinga

More News